Allergan Inc $166.61

up +0.96


24/4/2014 06:40 PM  |  NYSE : AGN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get AGN Trend Analysis - it has outperformed the S&P 500 by 26%

Partner Headlines

  1. Benzinga's M&A Chatter for Wednesday April 23, 2014

    Benzinga
  2. Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical ...

    GuruFocus
  3. Forest Laboratories Is an Option for Wealthy Investors Who Could Afford ...

    GuruFocus
  4. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces ...

    Benzinga
  5. Bill Ackman Talks Partnership With Valeant For Allergan Deal

    Benzinga
  6. Benzinga's Top Upgrades

    Benzinga
  7. Big Pharmas Swap Specialties

    IBD
  8. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  9. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  10. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  11. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  12. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  13. Ackman: No Laws Broken in Allergan Buy

    FoxBusiness
  14. Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq ...

    Benzinga
  15. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
  16. Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as ...

    Benzinga
  17. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  18. Nasdaq, Health Care Lead Stock Market Higher

    IBD
  19. Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

    Benzinga
  20. Valeant Bid For Allergan Draws Mixed Reaction

    IBD
  21. Indexes Extend Gains Amid Upside Earnings Surprises

    IBD
  22. Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares ...

    Benzinga
  23. UPDATE: Allergan Confirms Receipt of Unsolicited Proposal from Valeant, ...

    Benzinga
  24. Mid-Morning Market Update: Markets Gain; McDonald's Posts Lower Profit

    Benzinga
  25. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  26. Stocks Hitting 52-Week Highs

    Benzinga
  27. Morning Market Movers

    Benzinga
  28. Sterne Agee Expects Allergan to Resist Hostile Takeover by Valeant

    Benzinga
  29. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  30. Benzinga's Top #PreMarket Gainers

    Benzinga
  31. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  32. ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, ...

    Benzinga
  33. UPDATE: Valeant Proposes to Combine with Allergan at $48.30/Cash, 0.83 ...

    Benzinga
  34. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  35. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  36. Benzinga's M&A Chatter for Monday April 21, 2014

    Benzinga
  37. Valeant, Ackman Eye Allergan

    IBD
  38. Allergan and Valeant Rally on News of Potential Three Way Deal With Pershing ...

    Benzinga
  39. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  40. Pershing, Valeant Team Up in Bid to Buy Allergan

    FoxBusiness
  41. Market Wrap For April 16: Markets Hold On To Gains An Positive Yellen Comments ...

    Benzinga
  42. Stocks On Track For Third Gain; Allergan Rises

    IBD
  43. Benzinga's Volume Movers

    Benzinga
  44. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  45. Market Wrap For March 28: Markets Still Positive Despite Giving Up Early ...

    Benzinga
  46. Abbott Capturing Incremental Market Share

    GuruFocus
  47. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  48. Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains

    Benzinga
  49. Weekly CEO Sells Highlight: Cardinal Health, Envision Healthcare Holdings, ...

    GuruFocus
  50. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
Trading Center